AVE 16.7% 0.3¢ avecho biotechnology limited

newsletter is out, page-47

  1. 778 Posts.
    Hottod

    Yep, I am saying 2 things;

    -I am of the opinion that POH's manufacturing capability is not internal but reliant upon an external manufacturer not controlled by POH. (Contract manufacturing.)

    -I am also of the opinion that it would not be easy for manufacturing capability to be ramped up as has been suggested.


    having said that, I bought back in after having been told this. I think the Elixia stuff is just play money.
    Ramses
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $3.226K 1.116M

Buyers (Bids)

No. Vol. Price($)
52 92468918 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 76402411 25
View Market Depth
Last trade - 12.50pm 06/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.